Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Diagnoplex SA and Unilabs Sign a Collaboration Agreement

Published: Thursday, September 19, 2013
Last Updated: Thursday, September 19, 2013
Bookmark and Share
Agreement to market the Colox® non-invasive colon cancer screening test.

Diagnoplex SA and Unilabs have signed a collaboration agreement to commercialize Colox®, a minimally invasive colorectal cancer assay within the Unilabs network.

The test will be available initially in the Swiss and Swedish markets.

The agreement combines Diagnoplex’s capacity to develop “high-return” molecular assays with Unilabs’ leading position in the European diagnostics market.

The agreement builds on a solid collaborative effort between the two companies and enables Unilabs to further differentiate itself through innovative molecular testing.

“This agreement opens a new and exciting chapter for Diagnoplex” said Stavros Therianos, founder and CEO of Diagnoplex SA. “We are able to enter into a strong collaboration with a European market leader such as Unilabs thanks to a patient- focused strategy for clinical product development. This collaboration demonstrates that a step-by-step approach, for the development of molecular screening tests, can effectively lead to the commercial availability of medically relevant diagnostics”.

Fernando de Górgolas, Unilabs Group Marketing & Business Development Director, said, “This collaboration with Diagnoplex is consistent with our strategy of launching innovative tests, that can bring a real benefit to patients and the healthcare community. Colox will strengthen the role of our molecular genetics laboratories in the diagnosis and monitoring of colorectal cancer.”

Thierry Mauvernay, Delegate of the Board of Debiopharm Group - a lead investor in Diagnoplex - agreed, adding “We are delighted that Diagnoplex has been able to establish this collaboration with an important actor in diagnostic market. We believe the Colox blood test has the potential to greatly increase the percentage of people that will be correctly screened for colorectal cancer”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!